Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Shimlas shock Tuks by staying calm
2016-02-19

Description: KL News 2016 02 19  Varsitycup Tags: KL News 2016 02 19  Varsitycup
Prop Ox Nche was one of the substitutes who had a huge impact against Tuks in Pretoria on 15 February 2016. Nche and other Shimlas substitutes helped their team wipe out a massive deficit. Photo: Johan Roux.

He has never been involved in a match like this in his rugby career.
This is what Neil Claassen had to say about his team’s performance on 15 February 2016, when the Shimlas came up with one of the biggest fight-backs in the history of the Varsity Cup in Pretoria. According to the Shimlas Captain, his bench had a great impact, and this helped in shocking Tuks with 47-46 towards the end. This came after Tuks had been leading 43-15 in the 44th minute.

Great fighting spirit
The Shimlas' fighting spirit, and a new Varsity Cup points system in which converted tries may count up to 11 points, enabled them to wipe out this deficit.
“It was a tough match, especially after being so far behind,” Neil said.
“Coach (Hendro Scholtz) told us during half-time (when we were 15-36 behind) that we should stay calm."
“We weren't completely out of the game. We knew that if we eliminated unnecessary mistakes, we could make it.”

Impact from bench
This is the second consecutive match - the other was against Ikeys in Cape Town - where the Shimlas’ substitutes swayed the match. “The bench made a big difference,” Neil said. “We also scored an 11-point try, which helped a lot.”
The Shimlas’ fullback, Marco Mason, was named Player of the Match. He succeeded with a tricky conversion to gain victory for his team.

Injuries
The eighth man, Nardus Erasmus (knee) and flanker, Fiffy Rampeta (eye socket), sustained injuries, but should be able to play in the first home game against the Madibaz on 22 February 2016. The injured scrumhalf, Zee Mkhabela (concussion), could return for this match.
Shimlas are second on the log, with nine league points after two away matches. Maties has ten league points.

Young Guns get stuck
The University of the Free State (UFS') Young Guns got stuck 8-14 against Tuks in Pretoria on 15 February 2016.
Vishuis, the UFS's residence team, will start their onslaught in the residence league against Dagbreek in Stellenbosch on 22 February 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept